ImmuPharma (LON:IMM) Share Price Passes Below 200 Day Moving Average – Here’s What Happened

ImmuPharma plc (LON:IMMGet Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1.90 ($0.02) and traded as low as GBX 1.65 ($0.02). ImmuPharma shares last traded at GBX 1.68 ($0.02), with a volume of 198,040 shares trading hands.

ImmuPharma Stock Performance

The business has a 50 day moving average of GBX 1.74 and a two-hundred day moving average of GBX 1.89. The firm has a market capitalization of £7.01 million, a price-to-earnings ratio of -168.25 and a beta of 1.53.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

See Also

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.